A. ONAT Et Al. , "Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation," INTERNATIONAL JOURNAL OF OBESITY , vol.31, no.7, pp.1119-1125, 2007
ONAT, A. Et Al. 2007. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation. INTERNATIONAL JOURNAL OF OBESITY , vol.31, no.7 , 1119-1125.
ONAT, A., Can, G., HERGENC, G., YAZICI, M., KARABULUT, A., & ALBAYRAK, S., (2007). Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation. INTERNATIONAL JOURNAL OF OBESITY , vol.31, no.7, 1119-1125.
ONAT, A. Et Al. "Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation," INTERNATIONAL JOURNAL OF OBESITY , vol.31, no.7, 1119-1125, 2007
ONAT, A. Et Al. "Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation." INTERNATIONAL JOURNAL OF OBESITY , vol.31, no.7, pp.1119-1125, 2007
ONAT, A. Et Al. (2007) . "Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation." INTERNATIONAL JOURNAL OF OBESITY , vol.31, no.7, pp.1119-1125.
@article{article, author={A. ONAT Et Al. }, title={Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation}, journal={INTERNATIONAL JOURNAL OF OBESITY}, year=2007, pages={1119-1125} }